DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,871,000 | -45.7% | 241,605 | +0.6% | 0.00% | -100.0% |
| Q2 2021 | $8,965,000 | +85.8% | 240,193 | +27.3% | 0.00% | – |
| Q1 2021 | $4,825,000 | -18.5% | 188,717 | -29.8% | 0.00% | – |
| Q4 2020 | $5,922,000 | -26.9% | 268,874 | -40.3% | 0.00% | -100.0% |
| Q3 2020 | $8,099,000 | +228.4% | 450,207 | +363.8% | 0.00% | – |
| Q2 2020 | $2,466,000 | +412.7% | 97,059 | +271.0% | 0.00% | – |
| Q1 2020 | $481,000 | -87.3% | 26,159 | -84.8% | 0.00% | -100.0% |
| Q4 2019 | $3,780,000 | +530.0% | 171,600 | +310.9% | 0.00% | – |
| Q3 2019 | $600,000 | -72.4% | 41,762 | -69.7% | 0.00% | – |
| Q2 2019 | $2,170,000 | +150.6% | 137,746 | +94.8% | 0.00% | – |
| Q2 2018 | $866,000 | -57.0% | 70,700 | -66.4% | 0.00% | – |
| Q1 2018 | $2,013,000 | -30.8% | 210,591 | -34.7% | 0.00% | -100.0% |
| Q4 2017 | $2,911,000 | +8721.2% | 322,374 | +2796.4% | 0.00% | – |
| Q2 2016 | $33,000 | – | 11,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |